Akebia Therapeutics (AKBA) EBT Margin Growth (1y) (2018 - 2026)
Akebia Therapeutics (AKBA) EBT Margin Growth (1y) (2018 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT Margin Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 89.60 Bn | 87.73 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 35.82 Bn | 32.08 Bn | 1.97 Bn | 342.00 |
| 3 | Zoetis | 32.67 Bn | 30.73 Bn | 1.62 Bn | -166.00 |
| 4 | Takeda Pharmaceutical | 27.70 Bn | 23.64 Bn | 4.39 Bn | -5,404.00 |
| 5 | United Therapeutics | 23.15 Bn | 21.00 Bn | 648.10 Mn | -1,258.00 |
| 6 | RedHill Biopharma | 21.80 Bn | 21.80 Bn | - | - |
| 7 | Viatris | 20.16 Bn | 18.35 Bn | 1.16 Bn | 8,812.00 |
| 8 | Neurocrine Biosciences | 17.86 Bn | 16.55 Bn | 800.70 Mn | 2,773.00 |
| 9 | Elanco Animal Health | 12.67 Bn | 12.24 Bn | 785.00 Mn | 132.00 |
| 10 | Akebia Therapeutics | 339.12 Mn | 176.52 Mn | 41.25 Mn | -2,733.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -2,733.00 |
| Dec 31, 2025 | 2,955.00 |
| Sep 30, 2025 | 5,551.00 |
| Jun 30, 2025 | 2,006.00 |
| Mar 31, 2025 | 6,582.00 |
| Dec 31, 2024 | -5,014.00 |
| Sep 30, 2024 | -1,908.00 |
| Jun 30, 2024 | 16.00 |
| Mar 31, 2024 | 1,202.00 |
| Dec 31, 2023 | 849.00 |
| Sep 30, 2023 | 7,332.00 |
| Jun 30, 2023 | -4,465.00 |
| Mar 31, 2023 | 8.19 Mn |
| Dec 31, 2022 | -5,220.00 |
| Sep 30, 2022 | 1,033.00 |
| Jun 30, 2022 | 17,988.00 |
| Mar 31, 2022 | -8.18 Mn |
| Dec 31, 2021 | 44,482.00 |
| Sep 30, 2021 | 28,162.00 |
| Jun 30, 2021 | 3,992.00 |